Cell Proliferation, 54 (3), Article e12997
This is when pharmacies mix and combine medications to meet custom requirements
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Unlike native IGF-1 which has a short half-life of only 2030 minutes IGF-1 LR3 has been modified by replacing the third amino acid with arginine and extending the peptide chain by 13 additional amino acids
This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (76)
There is a lot of excitement around GLP-1 agonists, and it is the hope that one will end up being approved for NASH in the near future